Related references
Note: Only part of the references are listed.Associations Between Serum Vitamin D and Adverse Pathology in Men Undergoing Radical Prostatectomy
Yaw A. Nyame et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Associations between Vitamin D Status and Type 2 Diabetes Measures among Inuit in Greenland May Be Affected by Other Factors
Nina O. Nielsen et al.
PLOS ONE (2016)
Plasma Vitamin D and Prostate Cancer Risk: Results from the Selenium and Vitamin E Cancer Prevention Trial
Alan R. Kristal et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
Serum 25-Hydroxyvitamin D Concentrations and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial
Jeannette M. Schenk et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
Vitamin D Deficiency Predicts Prostate Biopsy Outcomes
Adam B. Murphy et al.
CLINICAL CANCER RESEARCH (2014)
Pharmacological effects of vitamin D and its analogs: recent developments
Amnon C. Sintov et al.
DRUG DISCOVERY TODAY (2014)
Positive association between circulating 25-hydroxyvitamin D levels and prostate cancer risk: new findings from an updated meta-analysis
Yonghua Xu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2014)
Low 25-OH Vitamin D is Associated with Benign Prostatic Hyperplasia
Mohammad-Ali Haghsheno et al.
JOURNAL OF UROLOGY (2013)
Predictors of Serum Vitamin D Levels in African American and European American Men in Chicago
Adam B. Murphy et al.
AMERICAN JOURNAL OF MENS HEALTH (2012)
The Vitamin D Receptor Agonist Elocalcitol Inhibits IL-8-Dependent Benign Prostatic Hyperplasia Stromal Cell Proliferation and Inflammatory Response by Targeting the RhoA/Rho Kinase and NF-κB Pathways
Giuseppe Penna et al.
PROSTATE (2009)
Metabolic factors associated with benign prostatic hyperplasia
J. Kellogg Parsons et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Inhibition of Vitamin D3 metabolism enhances VDR signalling in androgen-independent prostate cancer cells
SW Yee et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2006)
BXL628, a novel vitamin D3 analog arrests prostate growth in patients with benign prostatic hyperplasia: A randomized clinical trial
E Colli et al.
EUROPEAN UROLOGY (2006)
Molecular mechanisms mediating the anti-proliferative effects of Vitamin D in prostate cancer
J Moreno et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
Androgen receptor signaling and vitamin D receptor action in prostate cancer cells
S Murthy et al.
PROSTATE (2005)
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia
JD McConnell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)
MH Ahonen et al.
CANCER CAUSES & CONTROL (2000)
Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of bcl-2
SE Blutt et al.
ENDOCRINOLOGY (2000)
Share Paper
